Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Childhood Osteosarcoma
|
151 | 0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 | 0.010 | 1 | 2018 | 2018 | ||||||
Colon Carcinoma
|
275 | 0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 | 0.010 | 1 | 2009 | 2009 | ||||||
Hematologic Neoplasms
|
60 | 0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 | 0.010 | 1 | 2014 | 2014 | ||||||
Lip and Oral Cavity Carcinoma
|
172 | 0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 | 0.010 | 1 | 2014 | 2014 | ||||||
Lupus Erythematosus, Systemic
|
1172 | 0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 | 0.010 | 1 | 2018 | 2018 | ||||||
Malignant neoplasm of mouth
|
184 | 0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 | 0.010 | 1 | 2014 | 2014 | ||||||
Malignant tumor of colon
|
688 | 0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 | 0.010 | 1 | 2009 | 2009 | ||||||
melanoma
|
515 | 0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 | 0.010 | 1 | 2012 | 2012 | ||||||
Myocardial Infarction
|
680 | 0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 | 0.010 | 1 | 2015 | 2015 | ||||||
Osteosarcoma
|
178 | 0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 | 0.010 | 1 | 2018 | 2018 | ||||||
Osteosarcoma of bone
|
151 | 0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 | 0.010 | 1 | 2018 | 2018 | ||||||
Papillary thyroid carcinoma
|
204 | 0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 | 0.010 | 1 | 2018 | 2018 | ||||||
cervical cancer
|
268 | 0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 | 0.050 | 0.200 | 5 | 2012 | 2017 | |||||
Cervix carcinoma
|
283 | 0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 | 0.050 | 0.200 | 5 | 2012 | 2017 | |||||
Malignant tumor of cervix
|
245 | 0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 | 0.050 | 0.200 | 5 | 2012 | 2017 | |||||
Head and Neck Carcinoma
|
118 | 0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 | 0.030 | 0.333 | 3 | 2013 | 2014 | |||||
Malignant Head and Neck Neoplasm
|
118 | 0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 | 0.030 | 0.333 | 3 | 2013 | 2014 | |||||
Nasopharyngeal carcinoma
|
320 | 0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 | 0.040 | 0.500 | 4 | 2011 | 2018 | |||||
Lymphoma, Non-Hodgkin
|
197 | 0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 | 0.020 | 0.500 | 2 | 2009 | 2016 | |||||
Malignant neoplasm of stomach
|
615 | 0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 | 0.060 | 0.667 | 6 | 2002 | 2016 | |||||
Stomach Carcinoma
|
652 | 0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 | 0.060 | 0.667 | 6 | 2002 | 2016 | |||||
Rheumatoid Arthritis
|
2387 | 0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 | 0.030 | 0.667 | 3 | 2006 | 2018 | |||||
Liver carcinoma
|
942 | 0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 | 0.100 | 0.700 | 10 | 2009 | 2020 | |||||
Breast Carcinoma
|
2793 | 0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 | 0.070 | 0.714 | 7 | 2003 | 2016 | |||||
Malignant neoplasm of breast
|
3417 | 0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 | 0.070 | 0.714 | 7 | 2003 | 2016 |